Table 3.

Cumulative cases and deaths over 50 years (2023–2072) of the strategies which were the most cost-effective as identified in step 1 in PNG

Scenarios	No intervention	1X at age 35 self-collected HPV S&T	2X at age 30, 40 self-collected HPV S&T	2X at age 35, 40 self-collected HPV S&T	2X at age 35, 45 self-collected HPV S&T*	3X at age 30, 35, 40 self-collected HPV S&T	5-yearly (6X) 30–55 self-collected HPV S&T
Incidence
Cumulative cases over 2023–2072	108 204	88 509	74 623	75 323	77 183	65 852	52 158
Cases averted (2023–2072)	–	19 695	33 581	32 881	31 021	42 352	56 047
Mortality
Cumulative deaths over 2023–2072	75 731	61 716	52 247	52 789	53 899	46 378	37 487
Deaths averted (2023–2072)	–	14 015	23 484	22 942	21 833	29 353	38 244

*WHO recommendation of cervical screening for cervical cancer elimination was added.

PNG, Papua New Guinea; S&T, screen and treat.